Company Filing History:
3 out of 187 
2 out of 31 
1 out of 2 Years Active: 2015-2024
Title: Sameer Shrinivas Kunte: Innovator in Pharmaceutical Formulations
Introduction
Sameer Shrinivas Kunte is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations comprising triptan compounds. With a total of 6 patents to his name, Kunte's work has the potential to impact the treatment of migraine and other related conditions.
Latest Patents
Kunte's latest patents focus on innovative pharmaceutical compositions for intranasal administration. One of his inventions provides a composition that includes a salt of sumatriptan or a physiologically acceptable solvate, combined with an alkyl glycoside or saccharide alkyl ester. This formulation is designed to achieve a Tvalue of less than 30 minutes upon administration. Additionally, he has developed another composition that includes a triptan, a pharmaceutically acceptable vehicle, and a mucosal permeation enhancer, which aims to provide a pharmacokinetic profile substantially equivalent to subcutaneous administration of the triptan.
Career Highlights
Throughout his career, Sameer Kunte has worked with prominent companies in the pharmaceutical industry. He has been associated with Dr. Reddy's Laboratories and Upsher Smith Laboratories, where he has contributed to various research and development projects. His expertise in pharmaceutical formulations has been instrumental in advancing the efficacy of treatments available in the market.
Collaborations
Kunte has collaborated with several professionals in his field, including Rajesh Gandhi and Sreekanth Manikonda. These collaborations have fostered innovation and have led to the successful development of new pharmaceutical products.
Conclusion
Sameer Shrinivas Kunte is a distinguished inventor whose work in pharmaceutical formulations has the potential to enhance treatment options for patients. His contributions to the field are noteworthy, and his ongoing research continues to pave the way for future innovations.